Literature DB >> 15282319

Scrambled prion domains form prions and amyloid.

Eric D Ross1, Ulrich Baxa, Reed B Wickner.   

Abstract

The [URE3] prion of Saccharomyces cerevisiae is a self-propagating amyloid form of Ure2p. The amino-terminal prion domain of Ure2p is necessary and sufficient for prion formation and has a high glutamine (Q) and asparagine (N) content. Such Q/N-rich domains are found in two other yeast prion proteins, Sup35p and Rnq1p, although none of the many other yeast Q/N-rich domain proteins have yet been found to be prions. To examine the role of amino acid sequence composition in prion formation, we used Ure2p as a model system and generated five Ure2p variants in which the order of the amino acids in the prion domain was randomly shuffled while keeping the amino acid composition and C-terminal domain unchanged. Surprisingly, all five formed prions in vivo, with a range of frequencies and stabilities, and the prion domains of all five readily formed amyloid fibers in vitro. Although it is unclear whether other amyloid-forming proteins would be equally resistant to scrambling, this result demonstrates that [URE3] formation is driven primarily by amino acid composition, largely independent of primary sequence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282319      PMCID: PMC479727          DOI: 10.1128/MCB.24.16.7206-7213.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

Review 1.  Protein misfolding, evolution and disease.

Authors:  C M Dobson
Journal:  Trends Biochem Sci       Date:  1999-09       Impact factor: 13.807

2.  Prions affect the appearance of other prions: the story of [PIN(+)].

Authors:  I L Derkatch; M E Bradley; J Y Hong; S W Liebman
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

3.  Prion domain initiation of amyloid formation in vitro from native Ure2p.

Authors:  K L Taylor; N Cheng; R W Williams; A C Steven; R B Wickner
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

4.  Yeast prion protein derivative defective in aggregate shearing and production of new 'seeds'.

Authors:  A S Borchsenius; R D Wegrzyn; G P Newnam; S G Inge-Vechtomov; Y O Chernoff
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  Equilibrium folding properties of the yeast prion protein determinant Ure2.

Authors:  S Perrett; S J Freeman; P J Butler; A R Fersht
Journal:  J Mol Biol       Date:  1999-07-02       Impact factor: 5.469

6.  Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein.

Authors:  Ulrich Baxa; Vladislav Speransky; Alasdair C Steven; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation.

Authors:  D C Masison; M L Maddelein; R B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

8.  Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.

Authors:  S Liemann; R Glockshuber
Journal:  Biochemistry       Date:  1999-03-16       Impact factor: 3.162

9.  Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae.

Authors:  L Bousset; H Belrhali; J Janin; R Melki; S Morera
Journal:  Structure       Date:  2001-01-10       Impact factor: 5.006

10.  The yeast prion Ure2p retains its native alpha-helical conformation upon assembly into protein fibrils in vitro.

Authors:  Luc Bousset; Neil H Thomson; Sheena E Radford; Ronald Melki
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

View more
  90 in total

1.  Amyloid of the Candida albicans Ure2p prion domain is infectious and has an in-register parallel β-sheet structure.

Authors:  Abbi Engel; Frank Shewmaker; Herman K Edskes; Fred Dyda; Reed B Wickner
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

Review 2.  Yeast prions assembly and propagation: contributions of the prion and non-prion moieties and the nature of assemblies.

Authors:  Mehdi Kabani; Ronald Melki
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

3.  Perfecting precision of predicting prion propensity.

Authors:  Daniel C Masison
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-12       Impact factor: 11.205

4.  Repeat domains of melanosome matrix protein Pmel17 orthologs form amyloid fibrils at the acidic melanosomal pH.

Authors:  Ryan P McGlinchey; Frank Shewmaker; Kan-Nian Hu; Peter McPhie; Robert Tycko; Reed B Wickner
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

Review 5.  Prion amyloid structure explains templating: how proteins can be genes.

Authors:  Reed B Wickner; Frank Shewmaker; Herman Edskes; Dmitry Kryndushkin; Julie Nemecek; Ryan McGlinchey; David Bateman; Chia-Lin Winchester
Journal:  FEMS Yeast Res       Date:  2010-12       Impact factor: 2.796

6.  A prion of yeast metacaspase homolog (Mca1p) detected by a genetic screen.

Authors:  Julie Nemecek; Toru Nakayashiki; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

7.  Chromatin condensing functions of the linker histone C-terminal domain are mediated by specific amino acid composition and intrinsic protein disorder.

Authors:  Xu Lu; Barbara Hamkalo; Missag H Parseghian; Jeffrey C Hansen
Journal:  Biochemistry       Date:  2009-01-13       Impact factor: 3.162

8.  Effect of domestication on the spread of the [PIN+] prion in Saccharomyces cerevisiae.

Authors:  Amy C Kelly; Ben Busby; Reed B Wickner
Journal:  Genetics       Date:  2014-05-08       Impact factor: 4.562

9.  Parallel beta-sheets and polar zippers in amyloid fibrils formed by residues 10-39 of the yeast prion protein Ure2p.

Authors:  Jerry C C Chan; Nathan A Oyler; Wai-Ming Yau; Robert Tycko
Journal:  Biochemistry       Date:  2005-08-09       Impact factor: 3.162

10.  A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes.

Authors:  James A Hebda; Ishu Saraogi; Mazin Magzoub; Andrew D Hamilton; Andrew D Miranker
Journal:  Chem Biol       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.